
Reconstitution

Weight & Metabolism · 10mg
CAS 2381089-83-2
Retatrutide, also written as Reta or the Reta peptide and sometimes mistyped Retatrude, R3ta peptide, or Reda peptide, is a triple-agonist research peptide studied across three of the most discussed metabolic targets in the current literature: the GLP-1, GIP, and glucagon receptor pathways. Where earlier compounds engaged one or two of these receptors, retatrutide is studied for reaching all three at once, which is why it sits at the centre of appetite-signalling and metabolic-balance research. The 10mg vial is the standard entry format and divides cleanly into the reference aliquots most laboratories work with.In preclinical and in-vitro settings, retatrutide is investigated for how simultaneous engagement of the three receptors influences appetite signalling, glucose-handling models, and body-composition pathways. The interest is in the interaction between receptors rather than any single one, and the metabolic literature approaches these triple-agonist compounds as tools for studying signalling rather than as finished products.Retatrutide is frequently studied alongside single- and dual-agonist peptides for comparison, and our library guide on retatrutide versus tirzepatide walks through how the receptor profiles differ. Researchers running longer investigation blocks often step up to the Retatrutide 20mg vial for better per-milligram value, while the 10mg format suits shorter protocols or a first reference batch. Both vials carry the same CAS reference, 2381089-83-2.Every 10mg vial of retatrutide ships lyophilised (freeze-dried) with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number printed on the label. Reconstitute with bacteriostatic water on arrival: add it slowly down the inside wall of the vial, swirl gently to dissolve, and never shake. Store the unopened vial refrigerated at 2 to 8°C; once reconstituted, keep the solution refrigerated and avoid repeated freeze-thaw cycles.Buying retatrutide in Australia is straightforward: every vial is dispatched from within Australia with free Australia Post Express shipping to every state and territory, no minimum spend, and tracking on every parcel. There are no customs delays and no international freight uncertainty. Checkout accepts card, PayPal, or PayID, each order is sealed under argon, and a 24-hour payment reservation holds your stock from the moment you order. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.
Retatrutide carries 175 indexed publications, 34 registered trials, 6 with Australian sites, 39,578 monthly readers on Wikipedia. Research activity sits at 73 papers in the past twelve months against 57 the year before.
High-intent searches for GLP-1, GIP, and glucagon-pathway research peptides.
175 papers, 73 this year · 34 trials, 6 in Australia · 39,578 readers (-29%) · S tier
Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.
Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.
Retatrutide 10mg arrives sealed and research-ready, with a written preparation and storage card in every order. Prepare and store it as set out below, and use the reconstitution calculator to work out your concentration and draw volume before you begin.
Your Retatrutide 10mg vial arrives securely packaged. Refrigerate it sealed at 2–8°C until you are ready to prepare.
Add Bacteriostatic Water slowly against the vial wall, then swirl gently. Never shake.
Once prepared, aliquot and freeze at −20°C. Avoid repeated freeze–thaw cycles.
“Well packed, sealed perfectly, and dispatched faster than expected. Easily the smoothest order I've placed.”
“Express tracking the whole way and the vial arrived in pristine condition. Arrived two days after dispatch.”
“Third order now and the quality is identical every time. The preparation notes in the box are genuinely useful.”
“Great packaging and fast dispatch. Took a day longer than the estimate but the tracking kept me informed throughout.”
“Discreet, well-protected parcel with clear labelling. Exactly the transparency I was after.”
“Reconstitution guidance was clear and the vial was flawless. Support answered my question within the hour.”
Educational and product-logistics information only. Nothing here is medical advice or a therapeutic claim.
Research-grade retatrutide pricing per vial, per larger format, and per milligram, with a comparison to what a future pharmacy supply might look like.
Read →Two of the most studied metabolic peptides compared, receptor targets, research context, and what the difference means in practice.
Read →A single GLP-1 agonist next to a GLP-1, GIP, and glucagon triple agonist, and what the receptor reach means for research.
Read →Also Searched As·Retatrutide is also searched as Reta peptide, Reta, R3ta peptide, Reda peptide, Ratatouille peptide, Retatrude, Retatrutide peptide, Skinny jab, Triple G peptide.
Retatrutide appears in 175 indexed publications going back to 2022, including 73 in the past twelve months. 34 registered trials appear on ClinicalTrials.gov, 6 with Australian sites.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 0 |
|---|---|
| 2016 | 0 |
| 2017 | 0 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 0 |
| 2021 | 0 |
| 2022 | 2 |
| 2023 | 16 |
| 2024 | 41 |
| 2025 | 58 |
| 2026 | 58 |